Deadline to Claim Your Payout from the AlloVir $ALVR Settlement Is in 3 Months - TradingView
3 days ago • Google News
Allovir Inc (ALVR)
US$ 9.811.55%
Price Chart
Key Statistics
Market Cap
$ 49.48M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
9.43K
52W High
$ 24.15
52W Low
$ 7.96
Dividend Yield
0.00%
Beta
0.62
Technicals
50-Day MA
9.7253
200-Day MA
14.5505
52 Week High
24.15
52 Week Low
7.96
About ALVR
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating .
Employees
6
Headquarters
Waltham, MA
CEO
Mr. David L. Hallal
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg